Transplantation News

Deceased donor AKI, both ongoing and recovery, was associated with higher rates of graft failure following kidney transplantation, a study that determined AKI using a back-estimation of baseline serum creatinine showed.

Fully vaccinated transplant recipients see an almost 80% reduction in COVID-19 incidents compared with transplant recipients who are not fully vaccinated, according to a study published in Transplant Infectious Disease.

A CDC advisory panel voted unanimously in favor of recommending a third dose of the COVID-19 vaccine in patients who are moderately or severely immunocompromised, according to an American College of Rheumatology press release.

The FDA authorized a third dose of COVID-19 vaccine for certain immunocompromised patients but continued to say that other fully vaccinated people do not need a booster.

A third dose of the Moderna COVID-19 vaccine substantially improved protection for transplant recipients, according to findings published in the New England Journal of Medicine.

Patients who are immunocompromised may soon be eligible to receive a booster dose of COVID-19 vaccine in the United States.

Immunocompromised individuals have a number of justifiable concerns surrounding COVID-19. One of those concerns is that a two-dose vaccine schedule may not produce a sufficient antibody response to protect them from the virus.

NephroSant, a startup operating out of the University of California, San Francisco that developed a test to detect graft rejection following kidney transplantation, has hired Gina Ford, RPh, MBA, as its new chief commercialization officer.

Health-related quality of life scores after kidney transplantation varied between patients who survived for at least 3 years and those who died during this time, leading researchers to suggest such tools may help identify at-risk patients.

Among kidney transplant recipients in France, elevations of three specific biomarkers –including those showing inflammation, cardiac injury and thrombosis – were significantly associated with an increased risk for mortality due to COVID-19.